AXIM Biotechnologies Inc (AXIM)
0.01
0.00 (0.00%)
USD |
OTCM |
May 17, 15:56
AXIM Biotechnologies Profit Margin (Quarterly): -14.79K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -14.79K% |
| September 30, 2023 | |
| June 30, 2023 | -37.50K% |
| March 31, 2023 | -37.35K% |
| December 31, 2022 | -11.89K% |
| September 30, 2022 | -154.8K% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -167.4K% |
| September 30, 2021 | -40.50K% |
| June 30, 2021 | -25.73K% |
| March 31, 2021 | -2.65K% |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | -13.73K% |
| December 31, 2018 | -586.3% |
| September 30, 2018 | -21.43K% |
| June 30, 2018 | -20.54K% |
| March 31, 2018 | -19.40K% |
| December 31, 2017 | -9.30K% |
| Date | Value |
|---|---|
| September 30, 2017 | -16.82K% |
| June 30, 2017 | -15.11K% |
| March 31, 2017 | -2.82K% |
| December 31, 2016 | -9.69K% |
| September 30, 2016 | -18.58K% |
| June 30, 2016 | -16.80K% |
| March 31, 2016 | -6.81K% |
| December 31, 2015 | -41.00K% |
| September 30, 2015 | -7.88K% |
| June 30, 2015 | -12.89K% |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | 1.75% |
| June 30, 2013 | -275.0% |
| March 31, 2013 | -53.70% |
| December 31, 2012 | -37.41% |
| September 30, 2012 | -16.31% |
| June 30, 2012 | -40.69% |
| March 31, 2012 | -43.17% |
| December 31, 2011 | 12.18% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-167.4K%
Minimum
Dec 2021
-2.65K%
Maximum
Mar 2021
-54.74K%
Average
-37.35K%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -122.2% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -195.0% |
| Operating Margin (Quarterly) | -5.86K% |
| Return on Net Operating Assets | -195.5% |